相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability
Andrew J. King et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
Steven Fishbane et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study (vol 32, pg 870, 2017)
Aurelie Lenglet et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis
Radwa El Borolossy et al.
PEDIATRIC NEPHROLOGY (2016)
Nicotinamide and phosphate homeostasis in chronic kidney disease
Charles Ginsberg et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
Valentin David et al.
KIDNEY INTERNATIONAL (2016)
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD
Tamara Isakova et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study
Joachim H. Ix et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Relationships Between Serum and Urine Phosphorus With All-Cause and Cardiovascular Mortality: The Osteoporotic Fractures in Men (MrOS) Study
Julie R. Dominguez et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Cardiovascular Effects of Sevelamer in Stage 3 CKD
Colin D. Chue et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease
Kathleen M. Hill et al.
KIDNEY INTERNATIONAL (2013)
Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals CHS (Cardiovascular Health Study)
Joachim H. Ix et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Effects of Phosphate Binders in Moderate CKD
Geoffrey A. Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Npt2b Deletion Attenuates Hyperphosphatemia Associated with CKD
Susan C. Schiavi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Relation of Sex and Estrogen Therapy to Serum Fibroblast Growth Factor 23, Serum Phosphorus, and Urine Phosphorus: The Heart and Soul Study
Joachim H. Ix et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease
Tamara Isakova et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients
Emilio Gonzalez-Parra et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
Emily G. Farrow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
Rodrigo B. Oliveira et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults
Robert N. Foley et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients
Steven C. Cheng et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women
Sherri-Ann M. Burnett et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure
N Eto et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Regulation of intestinal phosphate transport -: I.: Segmental expression and adaptation to low-Pi diet of the type IIb Na+-Pi cotransporter in mouse small intestine
T Radanovic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Nicotinamide suppresses hyperphosphatemia in hemodialysis patients
Y Takahashi et al.
KIDNEY INTERNATIONAL (2004)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)
JJ Gassman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
分享论文
